Bosch expands pharma solid seminar range
Participants of the pharma solid seminars from Bosch Packaging Technology benefit from a mix of theoretical industry knowledge, long-term experience, and practical training in the local laboratories.
Practical trainings on globally trending topics.
Bosch Packaging Technology has expanded its range of seminars for the development and production of solid pharmaceuticals under the umbrella of the Bosch Packaging Academy. In response to an increasing demand, Bosch now offers more practical trainings on sought-after topics, for instance at the German sites in Schopfheim and Waiblingen.
Learning from industry experts
The lectures are given by Bosch associates from different departments together with external industry and research experts. Participants benefit from a mix of theoretical industry knowledge, long-term experience and practical training in the local laboratories. "Our goal is to consistently adapt the trainings to participants' needs," explains Dr Marcus Knöll, head of the pharma service department of the Bosch subsidiary Hüttlin GmbH in Schopfheim. "Due to keen interest, we have continuously expanded our range of seminars over the years. And most of them are fully booked within a very short time."
In 2016, the Schopfheim site offers specific operator trainings for granulation and fluid bed usage, as well as seminars focusing on scale-up, granulation and coating. In the scale-up seminar, for instance, lecturers provide a deeper insight into the possibilities of scale-up. "Our specialists train the participants regarding the ideal approach and explain all practical process steps in detail," says Dr Knöll.
Seminars on capsules and tablets
The site in Waiblingen, Germany, offers several capsule school workshops. The seminar series provides information about the production and pharmaceutical application of hard capsules, the development of formulations, as well as different filling technologies. Further seminars from Bosch include processes, current trends and developments in tablet pressing and coating for different therapeutic areas.
The structure of the seminars offers flexible possibilities to obtain the title "Specialist of Operation", "Expert of Solid", or “Master of Solid”. In addition to the seminar certificate, the competence centers award credit points in three different categories. Depending on the difficulty level, participants receive one, two or three credit points per completed training course.
Seminar schedule 2016 at a glance
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.